Shigeru Honda1, Takayuki Nagai, Akira Negi. 1. Department of Surgery, Division of Ophthalmology, Kobe University Graduate School of Medicine,Chuo-ku, Kobe 650-0017, Japan. sighonda@med.kobe-u.ac.jp
Abstract
BACKGROUND: To evaluate the anti-angiogenic effects of integrin alphavbeta3 specific antagonist BS-1417 on laser-induced choroidal neovascularization (CNV) in mice. METHODS: Male C57BL/6 mice were treated with daily intraperitoneal injections of BS-1417 or saline starting at the onset (day 0) of experiments. CNV was induced by laser photocoagulation the next day. Fluorescein angiograms (FA) and choroidal flatmount FITC-dextran perfusion were performed on experimental day 8. Histological and immunohistochemical examinations were performed with consecutive cryosections. Sub-confluent human vascular endothelial cells (HUVEC) were grown in vitro under various concentrations (0-10 microg/ml) of BS-1417 and the numbers of cell were measured at 48 hours of incubation. After fixation, immunocytochemistry was performed. RESULTS: BS-1417 significantly decreased the area of dye leakage determined by FA (40% of control, p = 0.0008) and reduced the CNV size found on choroidal flatmount (18% of control, p = 0.007). In histological findings, BS-1417 apparently suppressed the size of laser-induced CNV. Immunoreactivities for VEGF and integrin alphav were remarkably attenuated with BS-1417 compared to control. BS-1417 inhibited the growth and VEGF expression of HUVEC in vitro. CONCLUSIONS: The integrin alphavbeta3 may play a key role in the induction of laser-induced CNV. The antagonists for integrin alphavbeta3 may have therapeutic effects in CNV associated diseases such as age-related macular degenerations.
BACKGROUND: To evaluate the anti-angiogenic effects of integrin alphavbeta3 specific antagonist BS-1417 on laser-induced choroidal neovascularization (CNV) in mice. METHODS: Male C57BL/6 mice were treated with daily intraperitoneal injections of BS-1417 or saline starting at the onset (day 0) of experiments. CNV was induced by laser photocoagulation the next day. Fluorescein angiograms (FA) and choroidal flatmount FITC-dextran perfusion were performed on experimental day 8. Histological and immunohistochemical examinations were performed with consecutive cryosections. Sub-confluent human vascular endothelial cells (HUVEC) were grown in vitro under various concentrations (0-10 microg/ml) of BS-1417 and the numbers of cell were measured at 48 hours of incubation. After fixation, immunocytochemistry was performed. RESULTS:BS-1417 significantly decreased the area of dye leakage determined by FA (40% of control, p = 0.0008) and reduced the CNV size found on choroidal flatmount (18% of control, p = 0.007). In histological findings, BS-1417 apparently suppressed the size of laser-induced CNV. Immunoreactivities for VEGF and integrin alphav were remarkably attenuated with BS-1417 compared to control. BS-1417 inhibited the growth and VEGF expression of HUVEC in vitro. CONCLUSIONS: The integrin alphavbeta3 may play a key role in the induction of laser-induced CNV. The antagonists for integrin alphavbeta3 may have therapeutic effects in CNV associated diseases such as age-related macular degenerations.
Authors: Yue Ming; Peep V Algvere; Anne Odergren; Lennart Berglin; Ingeborg van der Ploeg; Stefan Seregard; Anders Kvanta Journal: Invest Ophthalmol Vis Sci Date: 2004-06 Impact factor: 4.799
Authors: John Paul SanGiovanni; Emily Y Chew; Traci E Clemons; Frederick L Ferris; Gary Gensler; Anne S Lindblad; Roy C Milton; Johanna M Seddon; Robert D Sperduto Journal: Arch Ophthalmol Date: 2007-09
Authors: Lin Ma; Kai Gu; Cheng-Hai Zhang; Xue-Tao Chen; Yi Jiang; Karsten Melcher; Juan Zhang; Min Wang; H Eric Xu Journal: Acta Pharmacol Sin Date: 2016-04-25 Impact factor: 6.150
Authors: Hani Salehi-Had; Mi In Roh; Andrea Giani; Toshio Hisatomi; Shintaro Nakao; Ivana K Kim; Evangelos S Gragoudas; Demetrios Vavvas; Samira Guccione; Joan W Miller Journal: PLoS One Date: 2011-04-29 Impact factor: 3.240